SCHEMBL1492983

SCHEMBL1492983

Cc1cc(-c2ccc(NC(=O)Nc3cccc(-c4cccnc4)c3)cc2)ccn1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PORCN Q9H237 3/20 0.69
PSEN1 P49768 4/20 0.69
PSEN2 P49810 4/20 0.69
APH1B Q8WW43 4/20 0.69
NCSTN Q92542 4/20 0.69
APH1A Q96BI3 4/20 0.69
PSENEN Q9NZ42 4/20 0.69
CNR1 P21554 5/20 0.67
KDR P35968 3/20 0.60
WNT3A P56704 3/20 0.58
CYP3A4 P08684 1/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
CNR2 P34972 1/20 0.52
MAPT P10636 1/20 0.52
HTT P42858 1/20 0.52
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492860 0.90 CNR1 (0.68) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1493023 0.86 CNR1 (0.65) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492902 0.85 PORCN (0.62) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492826 0.85 PSEN1 (0.61) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492870 0.84 PSEN1 (0.67) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1493028 0.84 PSEN1 (0.68) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL12650373 0.84 PSEN1 (0.68) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492884 0.84 PSEN1 (0.68) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492885 0.83 PORCN (0.71) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492858 0.83 CNR1 (0.65) PORCNPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 PORCN 3166/4885PSEN1 3/4885PSEN2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.